Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08).
Sunakawa Y, Sakamoto Y, Kawabata R, Ishiguro A, Akamaru Y, Kito Y, Takahashi M, Matsuyama J, Yabusaki H, Makiyama A, Suzuki T, Tsuda M, Yasui H, Hihara J, Takeno A, Inoue E, Ichikawa W, Fujii M.
Sunakawa Y, et al. Among authors: yabusaki h.
Oncologist. 2024 Aug 5;29(8):e997-e1002. doi: 10.1093/oncolo/oyae056.
Oncologist. 2024.
PMID: 38581687
Free PMC article.